Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;31(9):106617.
doi: 10.1016/j.jstrokecerebrovasdis.2022.106617. Epub 2022 Jun 27.

Retinal artery/vein occlusion complicating SARS-CoV-2 vaccinations

Josef Finsterer  1
Affiliations
Comment

Retinal artery/vein occlusion complicating SARS-CoV-2 vaccinations

Josef Finsterer. J Stroke Cerebrovasc Dis. 2022 Sep.
No abstract available

Keywords: COVID-19; Retinal artery; SARS-CoV-2; Stroke; Thrombolysis; Vaccination.

PubMed Disclaimer

Comment on

References

    1. Su CK, Au SCL. Isolated and combined unilateral central retinal artery and vein occlusions after vaccination. A review of the literature. J Stroke Cerebrovasc Dis. 2022;31(8) doi: 10.1016/j.jstrokecerebrovasdis.2022.106552. - DOI - PubMed
    1. Chen PJ, Chang YS, Lim CC, Lee YK. Susac syndrome following COVID-19 vaccination: a case report. Vaccines (Basel) 2022;10(3):363. doi: 10.3390/vaccines10030363. - DOI - PMC - PubMed
    1. Romano D, Morescalchi F, Romano V, Semeraro F. COVID-19 adenoviral vector vaccine and central retinal vein occlusion. Ocul Immunol Inflamm. 2022:1–3. doi: 10.1080/09273948.2022.2079534. - DOI - PubMed
    1. Dutta Majumder P, Prakash VJ. Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature. Indian J Ophthalmol. 2022;70(6):2191–2194. doi: 10.4103/ijo.IJO_592_22. - DOI - PMC - PubMed
    1. Vujosevic S, Limoli C, Romano S, Vitale L, Villani E, Nucci P. Retinal vascular occlusion and SARS-CoV-2 vaccination. Graefes Arch Clin Exp Ophthalmol. 2022:1–10. doi: 10.1007/s00417-022-05707-5. - DOI - PMC - PubMed

Substances